Logo

Universitätsmedizin, Ernst-Moritz-Arndt-Universität Greifswald
Department of Medicine A
Friedrich-Loeffler-Str. 23a
17475 Greifswald

Homepage

Project leader

Prof. Dr. Julia Mayerle

Prof. Dr. Julia Mayerle

Phone: +49 3834 867230
Fax: +49 3834 867234
Email  
   
Prof. Dr. Markus M. Lerch

Prof. Dr. Markus M. Lerch

Phone: +49 3834 867230
Fax: +49 3834 867234
Email  

Project staff

Dr. rer. nat. Steffen Teller

Phone: +49 3834 867243
Fax: +49 3834 867234
Email  

Institute presentation

The Medical Faculty of Greifswald University (EMAU-G) was established in 1456 and has a strong life sciences record focussed on cancer research and population-based epidemiology (e.g. Study of Health in Pommerania – SHIP). Both of these core programmes are well funded (currently >12Mio €). The Department of Medicine A was ranked number one in the annual research assessment exercise of the University for the last three consecutive years. The department research focus is on pancreatic disorders and currently more than 20 externally funded group members are working in basic or translational pancreas projects. The research of Prof. Lerch and Prof. Mayerle has been continuously funded by the German Research Foundation (DFG), the German Cancer Aid (DKH), the Federal Ministry of Education and Research (BMBF) and several private foundations since 1989. Over 5 years Greifswald University Hospital has established a Pancreas Centre for Northern Germany which initiated, coordinates and currently recruits for the first international multicentre, European phase III trial on chronic pancreatitis (EUROPAC-2) and is the largest continental contributor to the EUROPAC-1 study for patients with hereditary disorders of the pancreas. The second largest German contribution to the ESPAC-3 pancreatic cancer study was recruited in Greifswald. The group has a longstanding expertise in preclinical pancreas research and is internationally established for its expertise in translational projects on pancreatic disorders (5 patent submissions for clinical applications). Cathepsins and their role in pancreatic disorders have been the research focus of both Principal Investigators.

Top
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.
PLG_SYSTEM_COOKIEHINT_BTN_OK PLG_SYSTEM_COOKIEHINT_BTN_NOTOK